Stock market

Up 50% in the Past Year, is Insulet Stock a Buy?

Stock Markets7 minutes ago (Jun 30, 2021 11:30AM ET)Up 50% in the Past Year, is Insulet Stock a Buy?© Reuters. Up 50% in the Past Year, is Insulet Stock a Buy?

Insulin management provider Insulet (NASDAQ:PODD) has seen its stock rise over 50% in the past year as the demand for insulin solutions continues to grow. But does this stock’s fundamentals merit this kind of valuation? Read more to learn if this stock is still a buy.Insulet (PODD), a developer, maker, and marketer of insulin management systems, had a stellar year. PODD is up 9% in the past six months and up more than 51% in the past year.

Will PODD’s good fortune continue? Or will profit taking send PODD lower? These are the pressing questions investors are pondering following PODD’s epic upward run.

Below, I delve into the nuances of PODD to provide investors with what might be in store for the stock in the months ahead. Here is a quick look at PODD as it currently stands following a banner year.

Continue reading on StockNewsUp 50% in the Past Year, is Insulet Stock a Buy?Add a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s